Revenue Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual revenue in 2023 was 1.67 Billion TWD , down -25.29% from previous year.
Apex Biotechnology Corp.'s latest quarterly revenue in 2024 Q2 was 437.99 Million TWD , down -2.81% from previous quarter.
Apex Biotechnology Corp. reported a annual revenue of 2.24 Billion TWD in annual revenue 2022, up 5.28% from previous year.
Apex Biotechnology Corp. reported a annual revenue of 2.13 Billion TWD in annual revenue 2021, up 6.3% from previous year.
Apex Biotechnology Corp. reported a quarterly revenue of 450.65 Million TWD for 2024 Q1, up 9.86% from previous quarter.
Apex Biotechnology Corp. reported a quarterly revenue of 410.22 Million TWD for 2023 Q4, down -0.55% from previous quarter.

Annual Revenue Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Revenue of Apex Biotechnology Corp. (2023 - 2009)

Year	Revenue	Revenue Growth
2023	1.67 Billion TWD	-25.29%
2022	2.24 Billion TWD	5.28%
2021	2.13 Billion TWD	6.3%
2020	2 Billion TWD	-8.8%
2019	2.19 Billion TWD	7.6%
2018	2.04 Billion TWD	13.83%
2017	1.79 Billion TWD	1.82%
2016	1.76 Billion TWD	-4.56%
2015	1.84 Billion TWD	3.27%
2014	1.78 Billion TWD	-2.2%
2013	1.82 Billion TWD	-9.72%
2012	2.02 Billion TWD	7.98%
2011	1.87 Billion TWD	7.23%
2010	1.74 Billion TWD	21.6%
2009	1.43 Billion TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	437.99 Million TWD	-2.81%
2024 Q1	450.65 Million TWD	9.86%
2023 Q4	410.22 Million TWD	-0.55%
2023 Q2	417.28 Million TWD	-4.41%
2023 FY	1.67 Billion TWD	-25.29%
2023 Q1	436.53 Million TWD	-14.18%
2023 Q3	412.49 Million TWD	-1.15%
2022 Q3	605.47 Million TWD	-0.43%
2022 FY	2.24 Billion TWD	5.28%
2022 Q1	521.95 Million TWD	-7.01%
2022 Q4	508.63 Million TWD	-15.99%
2022 Q2	608.1 Million TWD	16.51%
2021 FY	2.13 Billion TWD	6.3%
2021 Q3	509.46 Million TWD	5.16%
2021 Q1	576.38 Million TWD	26.75%
2021 Q4	561.31 Million TWD	10.18%
2021 Q2	484.48 Million TWD	-15.94%
2020 Q2	529.08 Million TWD	3.35%
2020 Q1	511.93 Million TWD	-23.18%
2020 Q4	454.73 Million TWD	-10.77%
2020 FY	2 Billion TWD	-8.8%
2020 Q3	509.59 Million TWD	-3.68%
2019 Q3	465.75 Million TWD	-14.03%
2019 FY	2.19 Billion TWD	7.6%
2019 Q1	524.93 Million TWD	0.96%
2019 Q2	541.76 Million TWD	3.21%
2019 Q4	666.41 Million TWD	43.08%
2018 Q2	497.86 Million TWD	5.83%
2018 FY	2.04 Billion TWD	13.83%
2018 Q3	555.34 Million TWD	11.55%
2018 Q1	470.45 Million TWD	-0.34%
2018 Q4	519.94 Million TWD	-6.37%
2017 Q4	472.06 Million TWD	-1.34%
2017 Q1	424.99 Million TWD	15.18%
2017 Q3	478.44 Million TWD	13.97%
2017 FY	1.79 Billion TWD	1.82%
2017 Q2	419.8 Million TWD	-1.22%
2016 Q4	368.97 Million TWD	-8.5%
2016 FY	1.76 Billion TWD	-4.56%
2016 Q1	482.04 Million TWD	0.5%
2016 Q2	509.02 Million TWD	5.6%
2016 Q3	403.24 Million TWD	-20.78%
2015 Q3	470.7 Million TWD	11.33%
2015 FY	1.84 Billion TWD	3.27%
2015 Q1	474.28 Million TWD	-4.25%
2015 Q2	422.81 Million TWD	-10.85%
2015 Q4	479.65 Million TWD	1.9%
2014 Q1	423.22 Million TWD	19.42%
2014 Q4	495.34 Million TWD	15.71%
2014 Q3	428.08 Million TWD	-3.21%
2014 Q2	442.27 Million TWD	4.5%
2014 FY	1.78 Billion TWD	-2.2%
2013 Q3	454.27 Million TWD	-8.52%
2013 Q4	354.41 Million TWD	-21.98%
2013 FY	1.82 Billion TWD	-9.72%
2013 Q1	523.97 Million TWD	8.72%
2013 Q2	496.56 Million TWD	-5.23%
2012 Q2	550.92 Million TWD	2.59%
2012 FY	2.02 Billion TWD	7.98%
2012 Q3	456.17 Million TWD	-17.2%
2012 Q1	537.02 Million TWD	7.93%
2012 Q4	481.96 Million TWD	5.66%
2011 Q4	497.55 Million TWD	-7.14%
2011 Q1	364 Million TWD	-16.89%
2011 Q3	535.81 Million TWD	11.88%
2011 FY	1.87 Billion TWD	7.23%
2011 Q2	478.9 Million TWD	31.57%
2010 Q2	429.85 Million TWD	-0.12%
2010 Q4	437.98 Million TWD	-2.99%
2010 Q1	430.35 Million TWD	0.0%
2010 FY	1.74 Billion TWD	21.6%
2010 Q3	451.48 Million TWD	5.03%
2009 FY	1.43 Billion TWD	0.0%

Peer Revenue Comparison of Apex Biotechnology Corp.

Name	Revenue	Revenue Difference
Sinphar Pharmaceutical Co.,Ltd.	2.96 Billion TWD	43.416%
Panion & Bf Biotech Inc.	1.88 Billion TWD	10.911%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	2.08 Billion TWD	19.646%
GenMont Biotech Incorporation	318.01 Million TWD	-427.188%
Abnova (Taiwan) Corporation	382.05 Million TWD	-338.824%
Adimmune Corporation	1.78 Billion TWD	6.081%
Tanvex BioPharma, Inc.	61.41 Million TWD	-2630.027%
Polaris Group	7.48 Million TWD	-22310.6%
Energenesis Biomedical CO.,LTD.	7.15 Million TWD	-23321.864%
UnicoCell Biomed Co., Ltd.	24.58 Million TWD	-6718.24%
PELL Bio-Med Technology Co. Ltd.	18.03 Million TWD	-9197.05%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Revenue Summary of Apex Biotechnology Corp.

Annual Revenue Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Revenue of Apex Biotechnology Corp. (2023 - 2009)

Peer Revenue Comparison of Apex Biotechnology Corp.